AIFF (fireflyneuro.com) Profit After Tax

Official company branding of fireflyneuro.com (AIFF)

Firefly Neuroscience, Inc (AIFF) has developed a cloud service for digital EEG visualization, a move supported by the upward trend in the company's accumulated profit. The -0.01 mark serves as the key metric for this trend. This advancement enabled the implementation of AI-driven biomarker analysis for the treatment of dementia and ADHD. Currently, the issuer's scientific and technical capacities are fully utilized in the production of automated neurodiagnostic systems without operational downtime.

AIFF Firefly Neuro Company Net Income (07/04/2022 - 10/30/2026)

Financial and market metric breakdowns for Firefly Neuroscience (AIFF)

- stock value and consensus price forecast:
Market Price Firefly Neuro|AIFF - Analyst Consensus Forecast
- business market valuation indicators:
Market Valuation AIFF|AIFF - Enterprise Value
- issuer book value statistics:
Net Assets per Share Firefly Neuroscience|AIFF - Company Book Value|Market Value to Book Value fireflyneuro.com|AIFF - Company Total Assets
- debt burden and liquidity indicators:
Debt to Capital Firefly Neuroscience, Inc|AIFF - Long-Term Debt to Capital|Current Liabilities to Equity Firefly Neuroscience, Inc.|AIFF - Company Debts|Debt to Book Capitalization Ratio AIFF|AIFF - Company Long-Term Liabilities|Short-Term Debt Firefly Neuroscience|Intermediate Coverage Ratio fireflyneuro.com
- earnings and multiples data:
AIFF - Company Net Income
Basic company analysis:Firefly Neuro, AIFF
Signature product of fireflyneuro.com

For a fundamental valuation of Firefly Neuroscience, Inc (AIFF), it is critical to understand the monetization dynamics of AI solutions in neuroscience, particularly through cloud-based EEG analysis. This indicator captures daily net profit, reflecting real-time business efficiency, while the company's current profit serves as a benchmark for asset quality, where an upward trend signals expanding margins but warns of the risks of entering at local highs.

Key competitors

Company Net Income Biogen Idec (BIIB)|NBIX (Neurocrine Biosciences) - Net Profit|regencellbioscience.com - Profit After Tax|Net Profit AXSM|Net Financial Result ACADIA Pharma|Company Net Income Xenon Pharmaceuticals Inc XENE|Final Profit VKTX|Supernus Pharmaceuticals - Net Profit|Company Net Income catalystpharma.com|DNLI: Net Profit|Profit After Tax HRMY (Harmony Biosciences Inc)|Company Net Income Biohaven Pharmaceutical|Company Net Income AMLX|Net Income TRVI (Trevi Therapeutics)|PRAX - Company Net Income|Anavex Life Sciences Corp. - Net Income|Final Profit CBLL|PRTA - Company Net Income|ALEC (Alector, Inc.) - Company Profit|ANNX: Net Profit|Company Net Income Omeros (OMER)|Net Income NGNE|Net Profit AC Immune S.A.|Company Net Income Voyager Pharma (VYGR)|NMRA (Neumora Corp) - Final Profit|Company Net Income Scilex Holding Company SCLX|tevogen.com (TVGN) - Company Net Income|ACOG - Company Net Income|Net Financial Result cogrx.com CGTX|IKT: Net Profit|Net Income Cassava Pharma|ASRT (Assertio Holdings) - Net Profit|Coya (COYA) - Net Financial Result|Net Profit VTGN|OVID - Company Net Income|Company Net Income Acumen Pharma ABOS|CRVO: Company Profit|Alterity Therapeutics Ltd - Net Profit|Clene Inc. (CLNN) - Net Income|PEPG: Net Profit|Company Net Income jupiterneurosciences.com (JUNS)|Net Income RLMD|ANVS: Final Profit|Net Profit GRCE|Net Financial Result anewmeds.com|Company Net Income NeuroSense Therapeutics Ltd. NRSN|RVPH: Company Profit|MetaVia, Inc. - Net Profit|NeurAxis Inc (NRXS) - Net Income|HSDT: Net Profit|Passage Bio (PASG) - Net Profit|NEUP (Neuphoria Therapeutics, Inc.) - Net Profit|Minerva Neurosciences Inc (NERV) - Net Financial Result|Net Profit ATHA|ADXN: Profit After Tax|Net Profit ALZN (Alzamend Neuro)|CYCN (Cyclerion Therapeutics Inc.) - Profit After Tax|PTIX - Company Net Income|KTTA (Pasithea Therapeutics) - Company Profit|CRGT: Net Profit|Company Net Income Avenue Therapeutics Inc (ATXI)|Net Income BCLI|Net Profit caratherapeutics.com|Company Net Income Chromocell Therapeutics Corp. (CHRO)|ELYM (eliemtx.com) - Final Profit|Company Net Income Intra-Cellular Therapies, Inc. ITCI|Longboard (LBPH) - Company Net Income|Marinus Pharmaceuticals - Net Profit|Profit After Tax NKGN|NRBO: Net Profit|SAGE - Net Financial Result|Company Net Income Neurotrope|TRVN: Final Profit|Net Profit VIGL|WENA - Company Net Income|Net Profit CERE (Cerevel Therapeutics, Inc.)